News & Events
A medicine for high blood pressure can destroy protein dies in the brain.
- April 22, 2019
- Posted by: Wiley M. Wagner
- Category: Science
Various neurodegenerative diseases somehow have a number of very unpleasant symptoms and features that do not allow the brain to function as it was intended by its regulatory mechanisms initially. However, traditional approaches and methods for stopping or treating various neurodegenerative diseases are gradually becoming a thing of the past, giving way to new experimental approaches based on the use of new drugs. So, today, a team of medical researchers from the Cambridge Institute in the UK presented the results of their new study on the analysis of drugs for lowering blood pressure in their new role.
And this new role is precisely the ability of this medicine to quickly clean the brain of toxins and unnecessary components. We are talking about a drug called felodipine, which had previously become officially approved and tested by the British and American authorities in its widespread use.
However, studying the effect of this drug on experimental mice, which were previously induced patterns similar to neurodegenerative symptoms, scientists noted that in addition to reducing and regulating blood pressure, felodipine also allows you to run an internal process of autophagy, in which the brain is quickly and effectively cleared of unnecessary toxins and components, thereby confronting the accumulation of an excessive amount of protein plates – currently considered the main cause of the emergence and development of various neurodegene -cooperative diseases. However, further research in this area will be able to identify some additional patterns of influence.
Because the presented results were obtained in an experimental and, one can say, unsystematic way in which test mice were also induced with some additional factors and patterns of neurodegeneration — and this may mean that, under certain aspects, the results of such testing may differ. However, it remains to wait for further news from the experts and closely monitor the progress of their research.